Programme: Viral hepatitis B and C (deadline - March 28th, 2022, 18:00, KYI time)

The Order of the Ministry of Health of Ukraine № 1723 from August 11th, 2021 (as amended) approved the nomenclature of medicines, medical devices and auxiliaries to them, including the direction "Medicines and medical devices for the diagnosis and treatment of citizens with viral hepatitis B and C", which will be purchased for budget funds in 2022 year under the budget program 2301400 "Provision of medical measures of separate state programs and complex measures of program character".

The order of the Ministry of Health of Ukraine № 120 from January 19th, 2022 brought to the SE "Medical Procurement of Ukraine" the list of areas of prevention, diagnosis and treatment in 2022, including the abovementioned area.

According to sub-point 1 of point 1 of the Resolution of the Cabinet of Ministers of Ukraine № 169 from February 28th, 2022 procurement of medicines will be carried out without the use of procurement and simplified procurement procedures defined by the Law of Ukraine "On Public Procurement", according to the list and amounts approved by the order of the Ministry of Health of Ukraine № 434 from March 8th, 2022.

Based on the above, please provide commercial offers for the following medicines and the necessary documents listed below:

INN

Release form

Dosage

Unit

Quantity

for children with viral hepatitis B

Tenofovir disoproxil

tablets, capsules, pills

300 mg

tablets, capsules, pills

14 280 

Entecavir

tablets, capsules, pills

1 mg

tablets, capsules, pills

3 720 

Entecavir

tablets, capsules, pills

0,5 mg

tablets, capsules, pills

21 870 

Peginterferon alfa-2a

ampoules, vials, syringes

135 mkg/0,5 ml

ampoules, vials, syringes

-   

Peginterferon alfa-2a

ampoules, vials, syringes

180 mkg /0,5 ml

ampoules, vials, syringes

-   

for adult patients with viral hepatitis B

Tenofovir disoproxil

tablets, capsules, pills

300 mg

tablets, capsules, pills

795 540 

Entecavir

tablets, capsules, pills

1 mg

tablets, capsules, pills

170 520 

Entecavir

tablets, capsules, pills

0,5 mg

tablets, capsules, pills

25 920 

Peginterferon alfa-2a

ampoules, vials, syringes

180 mkg/0,5 ml

ampoules, vials, syringes

1 662 

for adult patients with viral hepatitis C

Sofosbuvir

tablets, capsules, pills

400 mg

tablets, capsules, pills

231 784 

Daclatasvir

tablets, capsules, pills

60 mg

tablets, capsules, pills

186 564 

Sofosbuvir and velpatasvir

tablets, capsules, pills

400 mg/100 mg

tablets, capsules, pills

825 804 

Ombitasvir, paritaprevir and ritonavir

tablets, capsules, pills

12,5 mg/75 mg/50 mg

tablets, capsules, pills

33 600 

Dasabuvir

tablets, capsules, pills

250 mg

tablets, capsules, pills

33 600 

for children with viral hepatitis C

Sofosbuvir

tablets, capsules, pills

400 mg

tablets, capsules, pills

-   

Ribavirin

tablets, capsules, pills

200 mg

tablets, capsules, pills

-   

Sofosbuvir and ledipasvir

tablets, capsules, pills

400 mg/90 mg

tablets, capsules, pills

224 

Sofosbuvir and ledipasvir

tablets, capsules, pills

200 mg/45 mg

tablets, capsules, pills

84 

Sofosbuvir and ledipasvir

pellets for oral usage

150 mg /33,75mg

packets

-   

Sofosbuvir and velpatasvir

tablets, capsules, pills

200 mg/50 mg

tablets, capsules, pills

794 

Sofosbuvir and velpatasvir

tablets, capsules, pills

400 mg/100 mg

tablets, capsules, pills

2 380 

Peginterferon alfa-2a

ampoules, vials, syringes

135 mkg/0,5 ml

ampoules, vials, syringes

48 

It is worth noting that the commercial offer must contain the following information:

  • prices per unit in UAH, without VAT on the condition of DAP (Kyiv, Kyiv region, Ternopil, Ternopil region). In case of impossibility of delivery to the specified regions, please indicate possible places of delivery;

  • if the goods originate from the Republic of Belarus or the Russian Federation, please indicate this additionally.

Please provide the following documents in addition to the commercial offer:

For registered medicines:

1. A copy of the current registration certificate for the medical product issued by the relevant authorized body in Ukraine. The documents are submitted by the bidder as part of the tender proposal, taking into account the requirements of current legislation of Ukraine, established before the registration of medical products that can be purchased by a person authorized to procure in the field of health care, including Art. 9, 9-1 of the Law of Ukraine "On Medical Products";

2. A copy of the instructions for medical use in the state language or a copy of the instructions for use of the medical product in the state language;

3. Copies of valid certificates of compliance with GMP requirements for production sites specified in the registration dossier, which are responsible for the release (certification) of a batch of finished medical product supplied (to be supplied) to Ukraine, presented in the original language (language other than the state one), and their authentic translation into the state (Ukrainian) language (if the certificate of compliance with the GMP requirements is included in the EudraGMP database or the US or Canadian FDA electronic register, the Participant may provide a printout of the EudraGMP database or the US FDA or Health Canada electronic register and their authentic translation into the state (Ukrainian) language.

OR 

a copy of the valid document issued by the State Service of Ukraine for Medical Products and Drug Control, which confirms the compliance of the conditions of production of the proposed medicines with the requirements for the production of medicines in Ukraine.

For unregistered medicines:

  1. A copy of the valid document confirming the registration of the medical product by the competent authority of the country of Manufacturer/Applicant or the United States of America, the Swiss Confederation, Japan, Australia, Canada, the Member States of the European Union.

  2. A copy of the instructions for use (other information on the use of the medical product) AND the summary of product characteristics approved in accordance with the regulatory requirements of the Applicant's country /Manufacturer or the United States, the Swiss Confederation, Japan, Australia, Canada, country members of the European Union according to the results of clinical trials, presented in the original language (language other than the state one), ALSO a translation of the instructions for use of the medicine (other information on the use of the medicine) and a summary of the product in the state (Ukrainian) language.

  3. A written commitment (in any form) of the Applicant /Manufacturer to register the medical product in Ukraine for its use in Ukraine before the delivery. 

In case where, during the registration of a medical product, there is a different Applicant than the Applicant in the country where the medical product is registered, such a written commitment to register the medical product in Ukraine before delivery may be signed by the Applicant when registering the medical product in Ukraine subject to the submission of a power of attorney (POA) as part of the tender offer from the Manufacturer/Applicant, confirming the authority to be the Applicant when registering a medical product in Ukraine.

  1. Copies of valid certificates of compliance with GMP requirements for production sites specified in the registration dossier, which are responsible for the release (certification) of a batch of finished medical product supplied (to be supplied) to Ukraine, presented in the original language (language other than the state one), and their authentic translation into the state (Ukrainian) language (if the certificate of compliance with the GMP requirements is included in the EudraGMP database or the US or Canadian FDA electronic register, the Participant may provide a printout of the EudraGMP database or the US FDA or Health Canada electronic register and their authentic translation into the state (Ukrainian) language.

OR 

a copy of the valid document issued by the State Service of Ukraine for Medical Products and Drug Control, which confirms the compliance of the conditions of production of the proposed medicines with the requirements for the production of medicines in Ukraine.

For not registered medicinal product included in the list of not registered medicinal products (according to international non-proprietary names) that may be imported into the territory of Ukraine for the purpose of supply based on the results of procurement made by a person authorized to procure in the field of health care for programs and implementation centralized health care measures at the expense of the state budget approved by the Cabinet of Ministers of Ukraine:

1. Copy of the current document that confirms medicine registration in the United States of America, Swiss Confederation, Japan, Australia, Canada or on the territory of EU member states and using the medicine in one of such countries.

2. Copies of: instructions for use of the medicinal product in the original language (in a language other than the national language) and a short characteristic of the medicine in the original language (in a language other than the national language) approved in accordance with the applicant's / manufacturer's country regulations AND translation of the instruction for use of the medicinal product and a short characteristic of the medicine in the state (Ukrainian) language

3. Copies of valid certificates of compliance with GMP requirements for production sites specified in the registration dossier, which are responsible for the release (certification) of a batch of finished medical product supplied (to be supplied) to Ukraine, presented in the original language (language other than the state one), and their authentic translation into the state (Ukrainian) language (if the certificate of compliance with the GMP requirements is included in the EudraGMP database or the US or Canadian FDA electronic register, the Participant may provide a printout of the EudraGMP database or the US FDA or Health Canada electronic register and their authentic translation into the state (Ukrainian) language.

OR 

a copy of the valid document issued by the State Service of Ukraine for Medical Products and Drug Control, which confirms the compliance of the conditions of production of the proposed medicines with the requirements for the production of medicines in Ukraine.

Given the limited time, we ask you to urgently send to the State Enterprise "Medical Procurement of Ukraine" until 18:00 of March 28th, 2022 to the e-mail address: This email address is being protected from spambots. You need JavaScript enabled to view it., a set of documents containing a commercial offer and the above information. If it is impossible to provide one of the documents, please specify this.

Please note that the provision of a price offer does not create any benefits for the market participant in procurement and does not impose any obligations on the State Enterprise "Medical Procurement of Ukraine" in relation to the market participant.

 

State Enterprise "Medical Procurement of Ukraine" 

+380 63 651 90 25

[email protected]

22 Khreshchatyk Str., 2nd floor, Kyiv, 01001

 

Subscribe

Each month we are sending our informational letter. Do not miss out!

Please fill the required field.
Please fill the required field.
© Copyright 2023 . Всі права захищено/ All rights reserved. Державне підприємство «Медичні закупівлі України»/ State Enterprise "Medical Procurement of Ukraine"